Related Experiment Video
Updated: Aug 23, 2026
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Therapy of hepatocellular cancer with iodine-131-Lipiodol
Jörn H Risse1, Christian Menzel, Frank Grünwald
1Radiology and Nuclear Medicine Institute, von-Stauffenberg-Str. 9, D - 56304 Bad Honnef, Germany. Joern.Risse@freenet.de
Abstract:
Most patients with hepatocellular carcinoma are not eligible for surgery at the time of primary diagnosis. Portal vein thrombosis is frequent and represents a contraindication for transarterial chemoembolisation. Transarterial therapy with iodine-131-Lipiodol is superior to systemic therapy in tumours up to diameters of 5 cm and may be performed even in cases with portal vein thrombosis. Compared to other intraarterial therapy procedures, iodine-131-Lipiodol shows the same efficacy but less side effects.
